Journal Article

Pre-dilution on-line haemofiltration <i>vs</i> low-flux haemodialysis: a randomized prospective study

Charles H. Beerenhout, Antinus J. Luik, Suzan G. J. Jeuken-Mertens, Otto Bekers, Paul Menheere, Linda Hover, Leny Klaassen, Frank M. van der Sande, Emile C. Cheriex, Natalie Meert, Karel M. Leunissen and Jeroen P. Kooman

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 20, issue 6, pages 1155-1163
Published in print June 2005 | ISSN: 0931-0509
Published online March 2005 | e-ISSN: 1460-2385 | DOI:
Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study

Show Summary Details


Background. Accumulation of larger molecular weight uraemic toxins molecules may have a negative effect on the cardiovascular and nutritional state of dialysis patients and influence uraemic symptomatology. Their clearance can be enhanced by the use of haemofiltration (HF).

Methods. The effects of low-flux haemodialysis (HD) (ultrapure dialysate; polyamide membranes) and pre-dilution on-line HF (1:1 blood/substitution ratio; target filtration volume: 1.2 times body weight) on cardiovascular and nutritional parameters, interdialytic levels of uraemic toxins and quality of life (QOL; Laupacis questionnaire) were assessed during 1 year follow-up. Forty patients were randomized.

Results. After 1 year, 27 patients were eligible for analysis (HF: 13 patients; HD: 14 patients). Left ventricular mass index did not change in the HF patients (127±33 → 131±36 g/m2 after 12 months) or in the HD group (135±34 → 138±32 g/m2). Also, there were no changes in pulse wave velocity, and 48 h systolic and diastolic blood pressures. Lean body mass, assessed by dual-energy X-ray absorptiometry, increased in the HF group (44.8±8.9 → 46.2±9.6 kg; P<0.05), but not in the HD group (49.4±9.2 → 50.6±8.8 kg), although differences between groups were not significant. Insulin-like growth factor-1 levels remained stable in the HF patients, but decreased in the HD group (P<0.05 between groups). QOL for physical symptoms improved in the HF group (4.2±1.2 → 5.0±1.1; P<0.05 within the HF group and P = 0.06 between groups), but not in the HD group (4.0±1.0 → 4.4±1.4). β2-microglobulin, complement factor D and homocysteine decreased significantly in the HF but not in the HD group, whereas l-ADMA, leptin and advanced glycation end-products-related fluorescence did not change.

Conclusions. No changes in cardiovascular parameters were observed during pre-dilution on-line HF compared with low-flux HD. Treatment with on-line HF resulted in marked changes in the uraemic toxicity profile, an improvement in physical well-being and a small improvement in nutritional state.

Keywords: cardiovascular; haemofiltration; homocysteine; left ventricular mass; pre-dilution on-line; pulse wave velocity

Journal Article.  5616 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.